Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-14

Clinical Trial Update: Cognitive Function and Patient-Reported Quality of Life Outcomes Investigation in Patients Taking Vorinostat

View source ↗

Summary

Completed clinical trial assessing cognitive function and patient-reported quality of life in patients taking vorinostat, with outcomes related to graft-versus-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolinza (vorinostat)

Snippet

Sponsor: Sung Choi, M.D. | Conditions: Quality of Life, Graft-vs-Host Disease | Status: COMPLETED